Article
APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.
BMC biology - 21 May 2022
Jakobsdottir G Maria, Brewer Daniel S, Cooper Colin, Green Catherine, Wedge David C
Abstract excerpt
BACKGROUND: The APOBEC3 (apolipoprotein B mRNA editing enzyme catalytic polypeptide 3) family of cytidine deaminases is responsible for two mutational signatures (SBS2 and SBS13) found in cancer genomes. APOBEC3 enzymes are activated in response to viral infection, and have been associated with increased mutation burden and TP53 mutation. In addition to this, it has been suggested that APOBEC3 activity may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
